BDBM285979 Methyl [4-(2-{3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]-1-oxido-5,6,7,8-tetrahydroquinolin-8-yl}-1H-imidazol-5-yl)phenyl]carbamate (enantiomer 1 and 2)::US10081617, Example 126::US10081617, Example 127

SMILES COC(=O)Nc1ccc(cc1)-c1cnc([nH]1)C1CCCc2cc(cnc12)-c1cc(Cl)ccc1-n1cnnn1

InChI Key InChIKey=NTGAOTATFYGWPD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 285979   

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285979(US10081617, Example 127 | Methyl [4-(2-{3-[5-chlor...)
Affinity DataIC50: 1.66nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM285979(US10081617, Example 127 | Methyl [4-(2-{3-[5-chlor...)
Affinity DataIC50: 121nMpH: 7.4Assay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2019
Entry Details
Go to US Patent